Alliance Healthcare

Category: Target

Alliance Healthcare is the UK's leading pharmaceutical wholesaler, delivering to over 17,800 dispensing points from 16 service centres nationwide. It is included here solely because it distributes Teva pharmaceutical products across the UK market, generating revenue for Israel's largest company.

Non-Israeli with ties Chemicals & Pharmaceuticals Business pressure Supply chain Generic Pharma
Buys from Israel: Teva Pharmaceutical Industries
HQ: United Kingdom Website Updated: 3 Feb 2026

Take Action

Apply pressure where it matters. Use these tools and personalise your message with evidence from this page.

Before taking action, review our Code of Conduct for professional standards and ethical guidelines.

Help Us Hold Alliance Healthcare Accountable

Your skills and knowledge can strengthen this campaign. Join our volunteer research team or share insider information securely.

Volunteer With Us Submit Intelligence

Leverage Your Expertise

Do you work in this sector? We need professionals who understand procurement cycles, regulatory compliance, and corporate governance. Don't just boycott - lead!

Decision-Maker Directory

Key individuals with influence over corporate partnerships and procurement decisions. Direct your correspondence to the most relevant role.

Marie Evans
Managing Director, Alliance Healthcare UK
Oversees UK wholesale distribution across 16 service centres
Public contact: Via corporate website
Matt (Operations Director)
VP UK Operations
Manages UK service centre network operations
Public contact: Via corporate website
Juan Guerra
SVP & Managing Director, International Wholesale (Cencora)
Oversees Alliance Healthcare's international wholesale operations at parent Cencora
Public contact: Via Cencora corporate website

Material Risk Framing

Frame your message around business risks. These talking points resonate with corporate stakeholders and institutional investors.

Reputational & Brand

As the UK's leading pharmaceutical wholesaler owned by Cencora (NYSE: COR, Fortune 500 #11), Alliance Healthcare's distribution of products from Israel's largest company, which the ICJ found faces a 'plausible' genocide case (January 2024), creates reputational exposure with NHS trusts, pharmacy chains, and the publicly listed parent company's ESG-conscious investors

Operational & Supply Chain

Alliance Healthcare's role as a distribution intermediary means it could face pressure from pharmacies requesting non-Teva alternatives; however, all major UK wholesalers currently distribute Teva products, limiting the impact of individual wholesaler pressure

Financial & Investor

Owned by Cencora (formerly AmerisourceBergen), a publicly listed US corporation with over $200 billion in annual revenue; public market listing creates sensitivity to ESG-driven shareholder resolutions and institutional investor pressure on supply chain ethics

Legal & Compliance

UK procurement law and emerging due diligence legislation may create obligations for wholesale distributors sourcing from companies contributing significant revenue to states facing international legal proceedings

Strategic Analysis

In-depth assessment of the company's position, vulnerabilities, and recommended approaches for effective engagement.

CHALLENGING PRIORITY TARGET MONITORING TARGET Strategic Vulnerability → Severity → Severity: 3.0, Vulnerability: 6.0

Lower severity, high vulnerability — momentum builders that fold quickly

Learn about our methodology — companies are categorised based on severity (harm potential) vs strategic vulnerability (campaign leverage).

Why do these scores change?

Unlike static boycott lists, our targeting model is dynamic. This company's position on the matrix is re-evaluated continually as we verify new contracts, divestments, or policy changes. Your reporting directly impacts this score.

Alliance Healthcare is included in this directory solely because of its role as the UK's leading distributor of Teva pharmaceutical products. We are not making a broader judgement on Alliance Healthcare's business practices. The focus is on the supply chain relationship that generates revenue for Israel's largest company.

Why Alliance Healthcare Matters

Teva supplies approximately one in six of all prescription medicines dispensed in the UK. As the UK's leading wholesale distributor, delivering to over 17,800 dispensing points from 16 service centres with twice-daily deliveries, Alliance Healthcare is a critical link in Teva's access to UK community pharmacies, dispensing doctors, and hospitals. While Alliance Healthcare does not manufacture Teva products, its distribution network is essential to Teva's UK market presence and revenue generation.

The Wholesaler Challenge

All major UK pharmaceutical wholesalers currently distribute Teva products, including AAH Pharmaceuticals and Phoenix Healthcare Distribution. This means simply switching wholesaler does not reduce Teva's market access. The effective action is for pharmacies to request non-Teva generic alternatives from their existing wholesaler, including Alliance Healthcare. The generic pharmaceutical market is highly competitive, and equivalent alternatives from non-Israeli manufacturers exist for most Teva products. Alliance Healthcare's own Almus brand already offers a range of generic medicines that may substitute for Teva equivalents.

Key Leverage Points

  • Pharmacy Demand: Pharmacies can specify non-Teva generics when ordering from Alliance Healthcare. Wholesale purchasing is demand-driven — if pharmacies stop ordering Teva products, Alliance Healthcare's procurement from Teva decreases
  • NHS Procurement: Hospital pharmacy leads and ICB procurement officials can include ethical sourcing criteria in tender specifications, influencing wholesale distribution patterns
  • Public Market Sensitivity: Parent company Cencora (NYSE: COR) is a Fortune 500 company with over $200 billion in annual revenue. As a publicly listed entity, it is subject to ESG-driven shareholder resolutions and institutional investor scrutiny on supply chain ethics
  • Alphega Pharmacy Network: Alliance Healthcare operates the Alphega Pharmacy network supporting over 6,800 independent pharmacy members across Europe, providing a channel through which ethical sourcing policies could influence Teva procurement at scale

Engagement Strategy

In addition to pressuring Alliance Healthcare directly, an effective approach targets the demand side: engage pharmacists and pharmacy owners to request non-Teva alternatives when placing wholesale orders. Alliance Healthcare's own Almus generics range may offer direct substitutes for some Teva products. For comprehensive medication alternatives, see our Teva alternatives guide, which covers substitutions across all major therapeutic categories. Given Cencora's public listing, institutional investors and pension funds may also be engaged on ESG grounds regarding the parent company's role in distributing products from Israel's largest company.

Evidence & Sources

Verified sources including NGO reports, regulatory filings, and primary documents. Use these to substantiate your correspondence.

Corporate Statement
2025-01-01
Alliance Healthcare UK: About Us

Confirms position as the UK's leading pharmaceutical wholesaler, delivering to over 17,800 dispensing points from 16 service centres nationwide with twice-daily deliveries

Open source
Corporate Statement
2025-01-01
Teva UK: About Teva in the UK

Teva confirms it supplies approximately one in six of all prescription medicines dispensed in the UK, distributed through the wholesale network including Alliance Healthcare

Open source
Corporate Statement
2023-08-30
AmerisourceBergen Becomes Cencora

Parent company rebranded from AmerisourceBergen to Cencora, trading on NYSE under ticker COR, unifying 46,000 employees globally under one identity

Open source
News
2021-06-02
AmerisourceBergen Completes Acquisition of Alliance Healthcare

AmerisourceBergen (now Cencora) acquired Alliance Healthcare from Walgreens Boots Alliance for approximately $6.5 billion, comprising $6.275 billion in cash and 2 million shares

Open source
Academic
2014-05-01
Samuel Neaman Institute: Teva's Contribution to Israel's Economy

Research shows Teva contributed approximately 10% of Israel's total industrial GDP (2003-2012), establishing why distribution of Teva products is strategically significant

Open source

Updates & Milestones

  1. Central Logistics Centre Opening

    New 300,000 sq ft automated Central Logistics Centre in Birmingham set to open, creating over 200 jobs and increasing UK warehouse space by 25%

  2. Parent Rebrands to Cencora

    AmerisourceBergen rebranded as Cencora (NYSE: COR), unifying Alliance Healthcare under the new global brand identity

  3. Acquired by AmerisourceBergen

    AmerisourceBergen (now Cencora) acquired Alliance Healthcare from Walgreens Boots Alliance for approximately $6.5 billion

  4. Walgreens Boots Alliance Formed

    Walgreens completed acquisition of Alliance Boots, forming Walgreens Boots Alliance. Alliance Healthcare continued as the wholesale division

  5. Rebranded to Alliance Healthcare

    The wholesale distribution division of Alliance Boots was rebranded as Alliance Healthcare

  6. Alliance Boots Merger

    Alliance UniChem merged with Boots Group in a deal worth approximately 7 billion pounds, forming Alliance Boots plc

  7. Alliance UniChem Formed

    Alliance Sante SA merged with UniChem PLC to form Alliance UniChem, creating one of Europe's largest pharmaceutical distributors

  8. UniChem Founded

    UniChem group established in the UK to serve wholesale pharmaceutical products to independent pharmacies

Disclaimer: All information on this page is published in the public interest, based on good-faith research from credible sources and aligned with the UN Guiding Principles on Business & Human Rights. Companies and individuals may request corrections or page removal via our Feedback Form.